MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - TSX:MDA - CA55293N1096 - Common Stock
34.07 CAD
+0.76 (+2.28%)
Overall MDA gets a fundamental rating of 6 out of 10. We evaluated MDA against 12 industry peers in the Aerospace & Defense industry. While MDA has a great profitability rating, there are some minor concerns on its financial health. MDA is growing strongly while it is still valued neutral. This is a good combination! These ratings would make MDA suitable for growth investing!
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
In the past year MDA had a positive cash flow from operations.
MDA had positive earnings in 4 of the past 5 years.
MDA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
MDA's Return On Assets of 3.63% is amongst the best of the industry. MDA outperforms 91.67% of its industry peers.
MDA's Return On Equity of 8.94% is amongst the best of the industry. MDA outperforms 100.00% of its industry peers.
MDA has a Return On Invested Capital (5.72%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.31%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of MDA (8.48%) is better than 91.67% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
The Operating Margin of MDA (10.97%) is comparable to the rest of the industry.
MDA's Operating Margin has improved in the last couple of years.
The Gross Margin of MDA (24.54%) is better than 66.67% of its industry peers.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
MDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MDA has been increased compared to 1 year ago.
MDA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.95 indicates that MDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MDA (1.95) is better than 83.33% of its industry peers.
The Debt to FCF ratio of MDA is 0.55, which is an excellent value as it means it would take MDA, only 0.55 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.55, MDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
MDA has a Debt to Equity ratio of 0.29. This is in the better half of the industry: MDA outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.95 |
ROIC/WACC0.64
WACC8.99%
2.3 Liquidity
MDA has a Current Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MDA (0.86) is worse than 83.33% of its industry peers.
MDA has a Quick Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a better Quick ratio (0.85) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 185.37% over the past year.
MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
The Revenue has grown by 57.21% in the past year. This is a very strong growth!
Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
3.2 Future
The Earnings Per Share is expected to grow by 46.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.27% on average per year.
EPS Next Y112.1%
EPS Next 2Y63.75%
EPS Next 3Y46.56%
EPS Next 5YN/A
Revenue Next Year52.35%
Revenue Next 2Y31%
Revenue Next 3Y23.27%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
MDA is valuated quite expensively with a Price/Earnings ratio of 29.12.
Compared to the rest of the industry, the Price/Earnings ratio of MDA is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.06. MDA is around the same levels.
With a Price/Forward Earnings ratio of 18.15, MDA is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA is on the same level as its industry peers.
MDA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.64, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.12 | ||
| Fwd PE | 18.15 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDA.
Based on the Price/Free Cash Flow ratio, MDA is valued cheaper than 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.06 | ||
| EV/EBITDA | 16.02 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 46.56% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y63.75%
EPS Next 3Y46.56%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (9/25/2025, 7:00:00 PM)
34.07
+0.76 (+2.28%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners30.22%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap4.30B
Analysts78.18
Price Target43.5 (27.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)-12.21%
PT rev (3m)22.34%
EPS NQ rev (1m)-1.14%
EPS NQ rev (3m)53.78%
EPS NY rev (1m)0%
EPS NY rev (3m)24.79%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)14.49%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.12 | ||
| Fwd PE | 18.15 | ||
| P/S | 3.17 | ||
| P/FCF | 6.06 | ||
| P/OCF | 4.47 | ||
| P/B | 3.35 | ||
| P/tB | 16.92 | ||
| EV/EBITDA | 16.02 |
EPS(TTM)1.17
EY3.43%
EPS(NY)1.88
Fwd EY5.51%
FCF(TTM)5.62
FCFY16.49%
OCF(TTM)7.63
OCFY22.39%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.26
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexcg growth 3Y59.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.95 |
F-Score6
WACC8.99%
ROIC/WACC0.64
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
EPS Next Y112.1%
EPS Next 2Y63.75%
EPS Next 3Y46.56%
EPS Next 5YN/A
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
Revenue Next Year52.35%
Revenue Next 2Y31%
Revenue Next 3Y23.27%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year177.81%
EBIT Next 3Y52.71%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A